How higher body mass index affects teens' braces, gums, and tooth health.
Official title: Influence of Body Mass Index on Gingival Health, White Spot Lesions, Whole Salivary Proinflammatory Cytokine and Adipokine Profile and Candida and Streptococcus Mutans Carriage Among Adolescents Undergoing Fixed Orthodontic Therapy
Run by University of Rochester · NCT07217756 · Data updated 2026-11-12
This project will test whether adolescents with higher BMI have more gum inflammation, tooth discoloration, and oral bacteria while wearing fixed braces.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 12 Years to 18 Years |
| Sex | All |
| Enrollment | 52 (estimated) |
| Sponsor | University of Rochester Academic / other |
| Locations | 1 site (Rochester, New York) |
| Status | Recruiting |
| Started | April 22, 2022 |
| Main results expected | November 1, 2026 |
| Study ends | November 1, 2026 |
| Registry record updated | October 20, 2025 |
| Trial ID | NCT07217756 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescents 12–17 years old scheduled for at least six months of fixed metal-bracket orthodontic therapy on both arches with all six mandibular anterior teeth present and mild-to-moderate lower crowding, whose parents/guardians provide permission, are ideal candidates.
✕Probably not a fit
Patients outside the age or treatment criteria, those with active or a history of periodontitis, systemic diseases (such as diabetes or HIV), tobacco users, pregnant or lactating females, or those with craniofacial syndromes are unlikely to receive direct benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective observational study enrolling adolescents aged 12–17 who are starting comprehensive fixed orthodontic treatment with metal braces on both arches. Participants will be grouped by BMI (normal 18.5–24.99 vs increased ≥25.0 kg/m2) and followed for at least six months during treatment. Investigators will measure gum inflammation, tooth decalcifications/discolorations, alignment of the lower incisors, and inflammatory and microbiological markers in saliva and gingival crevicular fluid at baseline and follow-up visits. No experimental interventions are given; the study aims to correlate BMI status with clinical oral and laboratory outcomes during orthodontic therapy.
Why it matters
Potential benefit: If positive, results could help identify higher-risk teens so clinicians can provide targeted oral hygiene guidance and closer monitoring during orthodontic treatment.
How similar studies have gone: Prior adult studies have linked obesity to greater periodontal inflammation and altered oral microbiology, but this specific question in adolescents undergoing fixed orthodontics has been little studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adolescents (12-17 years old); * patients scheduled to undergo comprehensive fixed orthodontic therapy (OT) (for at least 6 months with metal braces/wires) on both dental arches; * patients with increased BMI (≥25.0 Kg/m2) (test-Group); * patients with normal BMI \[18.5-24.99 (Kg/m2)\] (control-Group); * patients with all 6 mandibular anterior teeth present and mild-to-moderate mandibular crowding (\<7.5 mm); * patients and parents/guardians willing to provide signed assent/permission. Exclusion Criteria: * self-reported habitual tobacco product users; * patients with self-reported medical diseases such as hepatic diseases, blood disorders, cardiovascular diseases, HIV, diabetes mellitus, and viral infections; * patients with craniofacial syndromes and/or cleft lip and palate; * pregnant and/or lactating females (by self/parent report); * edentulous individuals; * patients with active or a history of periodontitis; * patients having undergone surgical and/or non-surgical periodontal therapy within the past 6 months; * patients with physical and/or mental/cognitive disabilities who are decisionally-impaired and not able to consent/assent for themselves; * patients who reported use of medications such as antibiotics, steroids (inhalers and/or pills), non-steroidal anti-inflammatory drugs, and antimicrobial mouth-rinses within the past 3 months or those who require prophylactic antibiotics prior to dental procedures; * patients undergoing cancer therapy; * underweight patients (BMI less than 18.5 Kg/m2); * patients with oral mucosal lesions such as median rhomboid glossitis and lichen planus; * patients with clinically visible carious teeth.
Where it's running
-
Eastman Institute for Oral Health, University of Rochester
Rochester, New York, United States Recruiting
Study contacts
- Principal investigator: Dimitrios Michelogiannakis, DDS, MS — Eastman Institute for Oral Health, University of Rochester
- Study coordinator: Dimitrios Michelogiannakis, DDS, MS
- Email: Dimitrios_Michelogiannakis@URMC.Rochester.edu
- Phone: 585-275-5012
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How incretin treatments affect muscle mass and function in people with overweight or obesity
This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.
-
Dose find for remimazolam plus alfentanil for gastroscopy in obese adults
This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.
-
Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults
This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.
-
Gut barrier and inflammation after fast-food overfeeding in adults
This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
GLP-1 weight‑loss medicine: finding who will benefit most
This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.